287 related articles for article (PubMed ID: 36752274)
1. Baicalin ameliorates high fat diet-induced nonalcoholic fatty liver disease in mice via adenosine monophosphate-activated protein kinase-mediated regulation of SREBP1/Nrf2/NF-κB signaling pathways.
Gao Y; Liu J; Hao Z; Sun N; Guo J; Zheng X; Sun P; Yin W; Fan K; Li H
Phytother Res; 2023 Jun; 37(6):2405-2418. PubMed ID: 36752274
[TBL] [Abstract][Full Text] [Related]
2. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
3. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
4. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
[TBL] [Abstract][Full Text] [Related]
5. Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
Mohammed HM
J Food Biochem; 2022 Jul; 46(7):e14149. PubMed ID: 35338494
[TBL] [Abstract][Full Text] [Related]
6. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
Han X; Ding C; Zhang G; Pan R; Liu Y; Huang N; Hou N; Han F; Xu W; Sun X
Biochem Biophys Res Commun; 2020 May; 525(4):895-901. PubMed ID: 32171530
[TBL] [Abstract][Full Text] [Related]
9. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
[TBL] [Abstract][Full Text] [Related]
10. Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis.
Li Y; Liu J; Ye B; Cui Y; Geng R; Liu S; Zhang Y; Guo W; Fu S
J Agric Food Chem; 2022 Aug; 70(34):10620-10634. PubMed ID: 35973099
[TBL] [Abstract][Full Text] [Related]
11. Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.
Valenzuela R; Illesca P; Echeverría F; Espinosa A; Rincón-Cervera MÁ; Ortiz M; Hernandez-Rodas MC; Valenzuela A; Videla LA
Food Funct; 2017 Apr; 8(4):1526-1537. PubMed ID: 28386616
[TBL] [Abstract][Full Text] [Related]
12. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
[TBL] [Abstract][Full Text] [Related]
13. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease.
Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD
Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698
[TBL] [Abstract][Full Text] [Related]
14. Total flavonoids of Broussonetia papyrifera alleviate non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signaling pathways.
Wang Q; Wei Y; Wang Y; Yu Z; Qin H; Zhao L; Cheng J; Shen B; Jin M; Feng H
Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Jun; 1869(5):159497. PubMed ID: 38649009
[TBL] [Abstract][Full Text] [Related]
15. Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice.
Ye J; Tian X; Wang Q; Zheng J; Yang Y; Xu B; Zhang S; Yuan F; Yang Z
Mar Drugs; 2022 May; 20(5):. PubMed ID: 35621963
[TBL] [Abstract][Full Text] [Related]
16. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
[TBL] [Abstract][Full Text] [Related]
17. Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.
Lin Q; Huang Z; Cai G; Fan X; Yan X; Liu Z; Zhao Z; Li J; Li J; Shi H; Kong M; Zheng MH; Conklin DJ; Epstein PN; Wintergerst KA; Mohammadi M; Cai L; Li X; Li Y; Tan Y
Hepatology; 2021 Jun; 73(6):2206-2222. PubMed ID: 32965675
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology analysis on mechanism of Jian Pi Qing Gan Yin decoction ameliorating high fat diet-induced non-alcoholic fatty liver disease and validated in vivo.
Liu W; Shang J; Deng Y; Han X; Chen Y; Wang S; Yang R; Dong F; Shang H
J Ethnopharmacol; 2022 Sep; 295():115382. PubMed ID: 35577161
[TBL] [Abstract][Full Text] [Related]
19. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
20. Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway.
Liu Y; Sun Z; Dong R; Liu P; Zhang X; Li Y; Lai X; Cheong HF; Wu Y; Wang Y; Zhou H; Gui D; Xu Y
Phytomedicine; 2024 Apr; 126():155437. PubMed ID: 38394735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
